YOLFTbeta
Sichuan Hebang Biotechnology Co Ltd

Sichuan Hebang Biotechnology Co Ltd

603077 · SHG · Basic Materials / Chemicals

1.99CNY-0.03 (-1.49%)

Price History

Full chart

Market Stats

Previous Close2.02
Open2.02
Day Range1.99 – 2.03
52-Week Range2.07 – 3.54
Volume75.90M
Market Cap19.34B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.04
Dividend Yield0.00%
Beta0.41
50-Day Avg2.35
200-Day Avg2.53

About

Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company provides original glass and smart glass, special glass, low-e coated glass, ultra-high efficiency silicon wafers, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products. In addition, it engages in the supply of oil and gas. The company was formerly known as SichuanHebang Biotechnology Co.,Ltd. and changed its name to Sichuan Hebang Biotechnology Corporation Limited in April 2021. The company was founded in 2002 and is based in Leshan, China.

Company Details

  • SectorBasic Materials
  • IndustryChemicals
  • CEOMr. Xiaoping Zeng
  • Employees5.08K
  • HeadquartersMianba Village, Leshan, China, China
  • Websitehttps://www.hebang.cn

Leadership

  • Mr. Xiaoping ZengChairman & GM · b. 1961
  • Mr. Jun WangCFO, Accounting Supervisor & Director · b. 1973
  • Ms. Siying JiangSecretary to the Board · b. 1987

Financials

Income Statement

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue844.37M1.43B1.87B1.74B1.60B2.19B2.86B3.46B4.74B6.01B5.97B5.26B9.99B13.04B8.82B8.55B7.19B
Growth (%)-+69.70%+30.54%-7.10%-7.77%+36.38%+30.97%+20.96%+36.83%+26.84%-0.66%-11.87%+89.85%+30.55%-32.33%-3.13%-15.91%
Cost of Revenue645.13M973.43M1.09B1.10B1.31B1.82B2.28B2.63B3.60B4.77B4.74B4.34B5.87B7.49B6.82B8.01B6.36B
Gross Profit199.24M459.44M807.36M635.34M293.73M364.20M585.93M834.97M1.14B1.24B1.22B916.12M4.11B5.55B2.00B537.18M828.02M
Gross Margin23.60%32.06%43.16%36.56%18.33%16.66%20.47%24.11%24.11%20.67%20.51%17.41%41.19%42.54%22.67%6.28%11.52%
Operating Expense152.70M208.16M322.41M170.89M223.39M-314.53M367.18M488.27M546.63M828.03M641.82M475.63M522.41M1.07B458.94M598.97M562.03M
Operating Income46.54M251.28M484.95M464.45M70.34M678.73M218.75M346.70M595.80M413.96M582.66M440.49M3.59B4.48B1.54B-61.79M265.99M
Operating Margin5.51%17.54%25.93%26.73%4.39%31.05%7.64%10.01%12.58%6.89%9.76%8.37%35.96%34.37%17.47%-0.72%3.70%
EBITDA145.19M424.90M801.39M659.67M307.32M421.62M620.40M811.95M1.14B1.18B1.28B1.17B4.28B5.40B2.41B924.25M507.00M
EBITDA Margin17.19%29.65%42.84%37.96%19.18%19.29%21.67%23.45%24.11%19.69%21.42%22.15%42.87%41.42%27.31%10.81%7.05%
Net Income44.16M172.80M366.28M334.89M64.44M671.76M239.87M317.81M517.54M363.09M516.85M40.94M3.02B3.81B1.28B31.46M-536.41M
Net Income Margin5.23%12.06%19.58%19.27%4.02%30.73%8.38%9.18%10.92%6.04%8.66%0.78%30.22%29.20%14.54%0.37%-7.46%
R&D---12.45M--3.81M28.15M34.76M31.14M38.30M39.68M33.31M67.93M47.35M30.63M17.31M
R&D as % of Total Revenue---0.72%--0.13%0.81%0.73%0.52%0.64%0.75%0.33%0.52%0.54%0.36%0.24%
Interest Expense23.62M80.47M129.68M118.77M82.29M138.79M125.17M114.41M69.76M61.73M63.63M91.65M79.06M52.03M28.64M66.88M125.39M
Interest Expense % of Total Revenue2.80%5.62%6.93%6.83%5.13%6.35%4.37%3.30%1.47%1.03%1.07%1.74%0.79%0.40%0.32%0.78%1.74%

Balance Sheet

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.17B3.12B3.68B5.05B5.58B9.13B11.20B12.93B13.11B13.29B14.48B14.74B17.92B24.10B24.54B29.65B28.21B
Total Liabilities2.43B2.14B2.34B1.64B2.29B4.38B4.62B2.15B1.83B2.09B3.03B3.43B3.29B4.34B4.32B10.64B10.25B
Total Equity648.07M974.62M1.34B3.40B3.29B4.75B6.29B10.46B10.99B10.97B11.23B11.14B14.25B19.12B19.58B18.63B17.88B
Cash348.09M111.70M358.19M1.35B308.90M146.18M568.55M308.72M830.71M1.34B590.52M845.86M1.71B4.59B3.06B7.00B6.70B
Total Debt1.99B1.69B1.88B1.41B1.95B3.27B3.57B1.24B915.53M1.16B1.86B2.15B1.37B1.82B1.62B7.30B-
Net Debt1.64B1.58B1.53B56.15M1.64B3.13B3.00B930.37M84.82M-178.69M1.27B1.30B-338.09M-2.77B-763.83M304.43M1.72B

Cash Flow

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow68.97M330.77M552.56M134.96M-407.48M204.67M449.20M575.26M176.94M944.39M162.92M368.85M3.20B2.64B200.76M467.93M1.08B
Investing Cash Flow-868.53M-630.92M-376.11M-243.54M-898.86M-612.18M-1.25B-2.18B795.43M-320.31M-1.28B-210.38M-1.72B-807.24M-902.65M-1.39B-
Financing Cash Flow814.92M67.80M70.38M1.10B239.42M261.66M1.23B1.33B-447.36M-160.03M367.06M78.45M-619.36M1.00B-943.60M4.85B-
Capital Expenditure848.53M571.00M345.17M273.83M598.53M716.77M1.13B677.45M508.53M363.57M662.54M197.09M1.74B936.18M828.74M1.12B1.26B
Free Cash Flow-779.56M-240.24M207.40M-138.87M-1.01B-512.09M-681.28M-102.19M-331.59M580.83M-499.62M171.76M1.46B1.71B-748.40M-648.30M-182.68M
Dividends Paid147.23M126.06M121.25M123.32M273.77M214.96M378.73M198.39M110.23M253.25M71.10M92.74M77.98M130.88M392.63M246.66M135.75M
FCF to OCF-1130.33%-72.63%37.53%-102.90%246.89%-250.20%-151.67%-17.76%-187.40%61.50%-306.67%46.57%45.72%64.60%-372.79%-138.54%-16.97%
Dividend Paid to FCF-18.89%-52.47%58.46%-88.80%-27.21%-41.98%-55.59%-194.14%-33.24%43.60%-14.23%53.99%5.34%7.66%-52.46%-38.05%-74.31%

Earnings

Report DateSep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 30, 2014Oct 30, 2014Mar 20, 2015Apr 29, 2015Jul 31, 2015Oct 29, 2015Dec 31, 2015Apr 28, 2016Aug 30, 2016Oct 30, 2016Feb 3, 2017Apr 28, 2017Aug 30, 2017Oct 30, 2017Feb 12, 2018Apr 27, 2018Jul 24, 2018Oct 24, 2018Dec 31, 2018Apr 24, 2019Aug 30, 2019Oct 31, 2019Dec 31, 2019Apr 22, 2020Aug 28, 2020Oct 31, 2020Dec 31, 2020Apr 26, 2021Jul 27, 2021Oct 14, 2021Mar 3, 2022Apr 25, 2022Jul 28, 2022Oct 27, 2022Feb 20, 2023Apr 28, 2023Aug 30, 2023Oct 21, 2023Apr 20, 2024Aug 30, 2024Oct 30, 2024Apr 29, 2025Aug 29, 2025
EPS Estimate-------------------------------------------0.000.000.000.000.000.000.00
EPS Actual0.010.000.010.000.000.000.010.100.00-0.000.010.010.000.010.010.010.010.010.020.010.010.020.010.030.02-0.010.010.020.020.01-0.000.01-0.030.030.030.080.130.140.120.180.090.040.050.000.000.000.000.000.000.00
Surprise--------------------------------------------------
Timing-------Pre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-market-Pre-marketAfter-hoursPre-market-Pre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours-------

Key Statistics & Ratios

Market Cap19.34B
Enterprise Value21.45B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.14
Price / Book1.03
EPS-0.04
Book Value2.29
Revenue (TTM)6.15B
Gross Profit (TTM)882.75M
EBITDA1.27B
Profit Margin-3.38%
Operating Margin21.26%
Return on Equity-1.99%
Return on Assets0.63%
Shares Outstanding8.83B
Shares Float5.50B
Beta0.41
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.04Jun 7, 2023
20221×
0.01May 12, 2022
20181×
0.02Jun 15, 2018
20171×
0.01Jul 5, 2017
20161×
0.00Jul 15, 2016
20151×
0.01Apr 22, 2015
20141×
0.01Jul 11, 2014
20131×
0.03Apr 17, 2013

Stock Splits

  • Jul 5, 2017196106:89139
  • Sep 2, 20153:1
  • Jul 11, 20142:1